PositiveID Corporation Completes Milestone in Development of Its Firefly Dx Prototype DELRAY BEACH, Fla., Jan. 13, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today...

A Clinical Update on the Search for a Universal Flu Vaccine: Presentation in Washington, DC on January 30, 2014 in Conjunction With the American Society for Microbiology (ASM) Biodefense Conference PHILADELPHIA, Jan. 28, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today that the ASM Biodefense Meeting is scheduled for January 27-29, 2014 at the Washington Marriott...

PositiveID Corporation Expands Its Biological Detection Capabilities to Address Avian Flu and Other Pandemic Viruses DELRAY BEACH, Fla., Sept. 14, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical...

LANI Phase II Completed -- Phase III Scheduled MELBOURNE, AUSTRALIA--(Marketwire - July 30, 2008) - Biota Holdings Limited (ASX: BTA) today announced that its second generation, influenza treatment, CS-8958, has successfully completed its initial...

346 Infectious Diseases and 7,316 Outbreaks Included in New Version of GIDEON Online LOS ANGELES, CA--(Marketwire - March 19, 2008) - GIDEON Informatics http://www.gideononline.com/content.htm today announced a new version of its Web-based solution, with data on 346 infectious...